Product Information
SENNA 8.8 MG/5 ML SYRUP is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0369 per ML under NDC 57237030124. Its NADAC has been published 193 times since Jan 25, 2023.
Strength
8.8 mg/5mL
Manufacturer
Rising Pharma Holdings Inc.NDC
57237030124
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SENNOSIDESApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007.60On Market Since
9/27/2022
Price Statistics
The NADAC for SENNA 8.8 MG/5 ML SYRUP has been published 193 times since Jan 25, 2023, and over the history we have for it it has risen 27.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0369 per ML |
|---|---|
| All-time high | $0.0464 (Nov 13, 2024) |
| All-time low | $0.0290 (Jan 25, 2023) |
| 52-week high | $0.0420 |
| 52-week low | $0.0369 |
| Median price | $0.0406 |
| Average price | $0.0400 |
| Largest weekly change | +31.9% (Feb 22, 2023) |
| Weeks tracked | 193 |
| Tracking since | Jan 25, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sennosides market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SENNA 8.8 MG/5 ML SYRUP?
The current National Average Drug Acquisition Cost (NADAC) for SENNA 8.8 MG/5 ML SYRUP, manufactured by Rising Pharma Holdings Inc., is $0.0369 per ML (NDC 57237030124), effective Sep 30, 2026.
How has the price of SENNA 8.8 MG/5 ML SYRUP changed over time?
Over the history we have for it, the NADAC for SENNA 8.8 MG/5 ML SYRUP has risen 27.5%. It has been tracked across 193 weekly CMS publications since Jan 25, 2023.
What are the highest and lowest recorded NADAC prices for SENNA 8.8 MG/5 ML SYRUP?
Since Jan 25, 2023, the NADAC for SENNA 8.8 MG/5 ML SYRUP has ranged from a low of $0.0290 (Jan 25, 2023) to a high of $0.0464 (Nov 13, 2024), with a median of $0.0406 per ML.
Are there cheaper alternatives to SENNA 8.8 MG/5 ML SYRUP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SENNA 8.8 MG/5 ML SYRUP in a comparable dosage form, but none are currently priced below it.
Who manufactures SENNA 8.8 MG/5 ML SYRUP?
SENNA 8.8 MG/5 ML SYRUP (NDC 57237030124) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.